Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Maine Center for Cancer Medicine and Blood Disorders
mi
from
Scarborough, ME
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Maine Center for Cancer Medicine and Blood Disorders
mi
from
Scarborough, ME
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Suburban Hospital Cancer Program
mi
from
Bethesda, MD
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Suburban Hospital Cancer Program
mi
from
Bethesda, MD
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Medstar Health Research Institute
mi
from
Hyattsville, MD
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Medstar Health Research Institute
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Hutzel Women's Health Specialists
mi
from
Detroit, MI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Hutzel Women's Health Specialists
mi
from
Detroit, MI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
William Beaumont Hospital
mi
from
Royal Oak, MI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Medicine and Dentistry of New Jersey
mi
from
Newark, NJ
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Kinston Medical Specialists
mi
from
Kinston, NC
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Kinston Medical Specialists
mi
from
Kinston, NC
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Cincinnati, Barrett Cancer Centre
mi
from
Cincinnati, OH
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Cincinnati, Barrett Cancer Centre
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
University of Oklahoma
mi
from
Oklahoma City, OK
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Abramson Cancer Center of the
mi
from
Philadelphia, PA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Abramson Cancer Center of the
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Univ. of Wisconsin Center for Women's Health and
mi
from
Madison, WI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Univ. of Wisconsin Center for Women's Health and
mi
from
Madison, WI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
BCCA - Cancer Centre for the Southern Interior
mi
from
Kelowna,
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
BCCA - Cancer Centre for the Southern Interior
mi
from
Kelowna,
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
George Washington University
mi
from
Washington,
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated:  3/27/2018
Montefiore Medical Center
mi
from
Bronx, NY
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Status: Enrolling
Updated: 3/27/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Green Tea in Breast Cancer Patients
Green Tea Supplement in Women With Incident Breast Cancer
Status: Enrolling
Updated:  3/28/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Green Tea in Breast Cancer Patients
Green Tea Supplement in Women With Incident Breast Cancer
Status: Enrolling
Updated: 3/28/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
A Double Blind Prospective Study of Metformin vs. Placebo in Overweight or Obese Post-menopausal Women at Elevated Risk for Breast Cancer
Status: Enrolling
Updated:  3/28/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
A Double Blind Prospective Study of Metformin vs. Placebo in Overweight or Obese Post-menopausal Women at Elevated Risk for Breast Cancer
Status: Enrolling
Updated: 3/28/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated:  3/28/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated: 3/28/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated:  3/28/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated: 3/28/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated:  3/28/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated: 3/28/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated:  3/28/2018
Fundacion Jimenez Diaz
mi
from
Madrid,
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
A Phase 1 Study of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
Status: Enrolling
Updated: 3/28/2018
Fundacion Jimenez Diaz
mi
from
Madrid,
Click here to add this to my saved trials
Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer
A Phase 1 Study With Dose Expansion of Dinaciclib (SCH 727965) in Combination With Epirubicin in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling
Updated:  3/29/2018
M D Anderson Cancer Center
mi
from
Houston, TX
Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer
A Phase 1 Study With Dose Expansion of Dinaciclib (SCH 727965) in Combination With Epirubicin in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling
Updated: 3/29/2018
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Meditation on Cognitive Function and Quality of Life
Effects of Meditation on Cognitive Function and Quality of Life
Status: Enrolling
Updated:  3/29/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Effects of Meditation on Cognitive Function and Quality of Life
Effects of Meditation on Cognitive Function and Quality of Life
Status: Enrolling
Updated: 3/29/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Meditation on Cognitive Function and Quality of Life
Effects of Meditation on Cognitive Function and Quality of Life
Status: Enrolling
Updated:  3/29/2018
Hospital Israelita Albert Einstein (HIAE)
mi
from
Sao Paulo,
Effects of Meditation on Cognitive Function and Quality of Life
Effects of Meditation on Cognitive Function and Quality of Life
Status: Enrolling
Updated: 3/29/2018
Hospital Israelita Albert Einstein (HIAE)
mi
from
Sao Paulo,
Click here to add this to my saved trials
Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
Efficacy of a Novel, High-Sensitivity, Portable, Hand-Held Gamma Camera Used Intraoperatively for Identification of Sentinel Lymph Nodes With Lymphoscintigraphy
Status: Enrolling
Updated:  3/29/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy
Efficacy of a Novel, High-Sensitivity, Portable, Hand-Held Gamma Camera Used Intraoperatively for Identification of Sentinel Lymph Nodes With Lymphoscintigraphy
Status: Enrolling
Updated: 3/29/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Soy Treatment for High-risk Women
Status: Enrolling
Updated:  3/30/2018
University of Southern California
mi
from
Los Angeles, CA
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
Soy Treatment for High-risk Women
Status: Enrolling
Updated: 3/30/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based Regimen
Status: Enrolling
Updated:  3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based Regimen
Status: Enrolling
Updated: 3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.
Pilot Study for the Effect of Exercise Intervention in Breast Cancer Patients With Arthralgias Receiving Aromatase Inhibitors
Status: Enrolling
Updated:  3/30/2018
Christiana Care/Helen F. Graham Cancer Center
mi
from
Newark, DE
The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.
Pilot Study for the Effect of Exercise Intervention in Breast Cancer Patients With Arthralgias Receiving Aromatase Inhibitors
Status: Enrolling
Updated: 3/30/2018
Christiana Care/Helen F. Graham Cancer Center
mi
from
Newark, DE
Click here to add this to my saved trials
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Pilot Biomarker Modulation Study of Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Status: Enrolling
Updated:  3/30/2018
Columbia University
mi
from
New York, NY
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Pilot Biomarker Modulation Study of Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Status: Enrolling
Updated: 3/30/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
Sonography Compared With MRI in Pre-Operative Evaluation of Patients With Breast Cancer to Determine Extent of Breast Disease
Status: Enrolling
Updated:  3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
Sonography Compared With MRI in Pre-Operative Evaluation of Patients With Breast Cancer to Determine Extent of Breast Disease
Status: Enrolling
Updated: 3/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
UAB Cancer Center
mi
from
Birmingham, AL
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
UAB Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
University of Chicago
mi
from
Chicago, IL
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research
mi
from
Baltimore, MD
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated:  4/1/2018
Baylor College of Medicine, Lester and Sue Smith Breast Center
mi
from
Houston, TX
Lapatinib and Trastuzumab With or Without Endocrine Therapy
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Status: Enrolling
Updated: 4/1/2018
Baylor College of Medicine, Lester and Sue Smith Breast Center
mi
from
Houston, TX
Click here to add this to my saved trials
Developing a Healthy Lifestyle in Breast Cancer Survivors
Developing a Healthy Lifestyle in Breast Cancer Survivors
Status: Enrolling
Updated:  4/3/2018
Healthy Eating and Activity Laboratory
mi
from
Knoxville, TN
Developing a Healthy Lifestyle in Breast Cancer Survivors
Developing a Healthy Lifestyle in Breast Cancer Survivors
Status: Enrolling
Updated: 4/3/2018
Healthy Eating and Activity Laboratory
mi
from
Knoxville, TN
Click here to add this to my saved trials
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
A Phase II Trial of Arimidex Plus Zoladex in the Treatment of Hormone Receptor Positive, Metastatic Carcinoma of the Breast in Premenopausal Women
Status: Enrolling
Updated:  4/3/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
A Phase II Trial of Arimidex Plus Zoladex in the Treatment of Hormone Receptor Positive, Metastatic Carcinoma of the Breast in Premenopausal Women
Status: Enrolling
Updated: 4/3/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
Click here to add this to my saved trials
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
mi
from
Burbank, CA
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
mi
from
Burbank, CA
Click here to add this to my saved trials
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
Mercy Cancer Center at Mercy San Juan Medical Center
mi
from
Carmichael, CA
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
Mercy Cancer Center at Mercy San Juan Medical Center
mi
from
Carmichael, CA
Click here to add this to my saved trials
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials